Hypercalcemia of Malignancy
Also known as: Hypercalcaemia of malignancy / Cancer related hypercalcemia / Cancer-related hypercalcemia / Paraneoplastic hypercalcemia / Paraneoplastic hypercalcaemia / Humoral hypercalcemia of malignancy (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00443 | Betamethasone | A systemic corticosteroid used to relieve inflammation in various conditions, including but not limited to allergic states, dermatologic disorders, gastrointestinal diseases, and hematological disorders. |
| DB00720 | Clodronic acid | A bisphosphonate used to treat osteoporosis in postmenopausal women, hypercalcemia of malignancy, and osteolysis. |
| DB01380 | Cortisone acetate | A steroid hormone used for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses and endocrine disorders associated with inadequate production of steroid hormones. |
| DB00741 | Hydrocortisone | A glucocorticoid used to treat corticosteroid-responsive dermatoses, endocrine disorders, immune conditions, and allergic disorders. |
| DB00710 | Ibandronate | A bisphosphonate used to treat osteoporosis in postmenopausal women. |
| DB00959 | Methylprednisolone | A corticosteroid used to treat inflammation or immune reactions across a variety of organ systems, endocrine conditions, and neoplastic diseases. |
| DB14644 | Methylprednisolone hemisuccinate | A water soluble corticosteroid used to treat severe allergic reactions, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematological disorders, neoplastic diseases, nervous system conditions, ophthalmic diseases, renal diseases, respiratory diseases, and rheumatic disorders. |
| DB00282 | Pamidronic acid | A bisphosphonate used to treat Paget's disease, to treat hypercalcemia of malignancy, and to treat osteolytic bone lesions. |
| DB00860 | Prednisolone | A glucocorticoid used to treat adrenocortical insufficiency, inflammatory conditions, and some cancers. |
| DB00635 | Prednisone | A corticosteroid used to treat inflammation or immune-mediated reactions and to treat endocrine or neoplastic diseases. |
| DB00884 | Risedronic acid | A bisphosphonate used to treat osteoporosis and Paget's disease. |
| DB00399 | Zoledronic acid | A bisphosphonate used to treat malignancy associated hypercalcemia, multiple myeloma, and bone metastasis from solid tumors. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB16278 | Parathyroid Hormone-Related Protein 1-36 | 1 | Withdrawn | 1 |
| DB05829 | Parathyroid hormone | 1 | Withdrawn | 1 |
| DB06285 | Teriparatide | 1 | Withdrawn | 1 |
| DB00399 | Zoledronic acid | 1 / 2 | Completed | 1 |
| DB06643 | Denosumab | 2 | Completed | 1 |
| DB00710 | Ibandronate | 3 | Unknown Status | 1 |
| DB00710 | Ibandronate | 3 | Withdrawn | 1 |
| DB00399 | Zoledronic acid | 3 | Completed | 1 |
| DB00399 | Zoledronic acid | 3 | Unknown Status | 1 |
| DB00399 | Zoledronic acid | 3 | Withdrawn | 1 |
| DB00399 | Zoledronic acid | Not Available | Terminated | 1 |